AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

EULAT Eradicate GBC

Recruitingn/aAges 18 Years - anyAllCentre Paul Strauss
💬

In plain words

What the trial is, and whether it could suit you

Gallstones are relatively frequent in women and constitute one of the main risk factors for gallbladder cancer (GBC). Currently, GBC diagnosis is mainly based on imaging (ultrasound or abdominal CT) associated with invasive examinations (biopsy and surgery), with no marker available to date to accurately predict risk and diagnose the disease early. The only curative treatment for GBC remains surgery with complete resection of tumors in early stages. Given the aggressiveness of GBC and the very limited therapeutic options, as well as the possibility of preventing GBC by cholecystectomy during the 10 to 20 years required for the development of gallbladder tumors, it is imperative to develop effective and efficient prevention strategies based on a prioritization of interventions according to environmental and genetic-molecular risk factors. The investigators aim to identify epidemiologic

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Cohort A. Patients with gallbladder cancer or dysplasia, both before and after the start of their anticancer treatment. Cohort B. Patients with cholelithiasis before cholecystectomy (only patients scheduled for cholecystectomy will be recruited) 2. Diagnosis confirmed in accordance with standard protocols of the participating hospitals 3. Men and women aged 18 or over Exclusion Criteria: 1. Any medical condition that present an unreasonable risk to the participant. 2. Any psychiatric condition that interferes with understanding informed consent.
💊

What it tests

  • None, observational study.
📍

Where

36 sites
Hospital Papa Francisco
Salta, Argentina
Sanatorio el Carmen
Salta, Argentina
Hospital Pablo Soria
San Salvador de Jujuy, Argentina
Complejo Hospitalario Viedma
Cochabamba, Bolivia
Hospital del Norte
Cochabamba, Bolivia
Hospital Obrero No. 2 (Caja Nacional del Seguro Social)
Cochabamba, Bolivia
Instituto Gastroenterológico
Cochabamba, Bolivia
Instituto Oncológico Nacional
Cochabamba, Bolivia

…and 28 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy